Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus
Open Access
- 1 June 2007
- journal article
- review article
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 4 (2) , 89-102
Abstract
Endothelial dysfunction is universal in diabetes, being intimately involved with the development of cardiovascular disease. The pathogenesis of endothelial dysfunction in diabetes is complex. It is initially related to the effects of fatty acids and insulin resistance on ‘uncoupling’ of both endothelial nitric oxide synthase activity and mitochondrial function. Oxidative stress activates protein kinase C (PKC), polyol, hexosamine and nuclear factor kappa B pathways, thereby aggravating endothelial dysfunction. Improvements in endothelial function in the peripheral circulation in diabetes have been demonstrated with monotherapies, including statins, fibrates, angiotensin-converting enzyme (ACE) inhibitors, metformin and fish oils. These observations are supported by large clinical end point trials. Other studies show benefits with certain antioxidants, L-arginine, folate, PKC-inhibitors, peroxi-some proliferator activated receptor (PPAR)-α and -γ agonists and phosphodiesterase (PDE-5) inhibitors. However, the benefits of these agents remain to be shown in clinical end point trials. Combination treatments, for example, statins plus ACE inhibitors and statins plus fibrates, have also been demonstrated to have additive benefits on endothelial function in diabetes, but there are no clinical outcome data to date. Measurement of endothelial dysfunction in cardiovascular research can provide fresh opportunities for exploring the mechanism of benefit of new therapeutic regimens and for planning and designing large clinical trials.Keywords
This publication has 178 references indexed in Scilit:
- Clinical Significance of Recent Lipid Trials on Reducing Risk in Patients with Type 2 Diabetes MellitusThe American Journal of Cardiology, 2007
- Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetesDiabetic Medicine, 2006
- Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic menDiabetes, Obesity and Metabolism, 2005
- Vascular effects of wine polyphenolsCardiovascular Research, 2004
- Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics–Brachial Artery Reactivity study)The American Journal of Cardiology, 2004
- Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin CDiabetic Medicine, 2004
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Impaired endothelial function with essential hypertension assessed by ultrasonographyAmerican Heart Journal, 1996
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJACC, 1996
- Circulating adhesion molecules in diseaseImmunology Today, 1993